RE:RE:RE:Working on oral vaccine, no refrigeration
bajanjohn wrote: If this is anywhere near close, you are right, if they can make it fast enough, this stock should be
$15-20-50.
It could really catch fire. As per the press release they will look for commercialization partners with preliminary results in hand. I'm thinking for the production scale needed here, the search and/or done deal(s) could get real media exposure, including some big pharma name dropping. The made-in-Canada vaccine product story will be loved by everyone.
PR said preliminary results in a few months. So September-ish. They'll be picking up the phone long before then, and thus word could keep spreading slowly with SP moving steadily upward all summer. Could be wrong of course, but liking this set up.